XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenue:        
Total revenue $ 74,136 $ 48,124 $ 190,010 $ 89,373
Operating expenses:        
Cost of product sales 21,171 7,907 46,347 16,349
Cost of royalty revenue 2,493 2,850 5,072 5,263
Research and development 11,437 9,911 17,545 24,199
Selling, general and administrative 36,832 16,636 59,014 36,515
Total operating expenses 71,933 37,304 127,978 82,326
Income from operations 2,203 10,820 62,032 7,047
Interest income 244 163 398 198
Interest expense (552) (422) (918) (844)
Other (expense) income (7,763) (5,013) (9,720) 487
Total other (expense) income, net (8,071) (5,272) (10,240) (159)
(Loss) income before income tax provision (5,868) 5,548 51,792 6,888
Income tax provision (3,582) (1,936) (17,184) (3,697)
Net (loss) income $ (9,450) $ 3,612 $ 34,608 $ 3,191
(Loss) earnings per share attributable to common stockholders:        
Basic (in dollars per share) $ (0.74) $ 0.28 $ 2.71 $ 0.24
Diluted (in dollars per share) $ (0.74) $ 0.27 $ 2.67 $ 0.24
Weighted average number of common shares outstanding:        
Basic (in shares) 12,836,116 13,108,998 12,773,727 13,116,370
Diluted (in shares) 12,836,116 13,262,164 12,951,788 13,293,920
Product sales, net        
Revenue:        
Total revenue $ 49,201 $ 19,621 $ 139,289 $ 36,741
Royalty revenue        
Revenue:        
Total revenue $ 24,935 $ 28,503 $ 50,721 $ 52,632